KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Goodwill & Intangibles (2018 - 2025)

Vir Biotechnology's Goodwill & Intangibles history spans 8 years, with the latest figure at $7.8 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 68.67% year-over-year to $7.8 million; the TTM value through Dec 2025 reached $7.8 million, down 68.67%, while the annual FY2025 figure was $7.8 million, 68.67% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $7.8 million at Vir Biotechnology, down from $24.9 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $50.6 million in Q1 2021 and bottomed at $7.8 million in Q4 2025.
  • The 5-year median for Goodwill & Intangibles is $42.5 million (2023), against an average of $39.7 million.
  • The largest annual shift saw Goodwill & Intangibles fell 1.03% in 2021 before it crashed 68.67% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $50.2 million in 2021, then dropped by 1.06% to $49.7 million in 2022, then dropped by 20.51% to $39.5 million in 2023, then crashed by 36.57% to $25.1 million in 2024, then plummeted by 68.67% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Goodwill & Intangibles are $7.8 million (Q4 2025), $24.9 million (Q3 2025), and $24.9 million (Q2 2025).